Sign in
Stories
Competition Key to Address Drug Shortages
Share
AIS Healthcare's Patient-First Approach
Availity Achieves CORE Certification for...
Biden administration asserts power to se...
AscellaHealth Forecasts Robust Outlook f...
Avenova-branded Products in EU Market
Biden Administration's Medicare Drug Pri...
Overview
API
The article underscores the link between price controls and drug shortages, focusing on essential hospital medications like Methotrexate and fludarabine. It delves into the FTC's investigation of distribution companies such as Cardinal Health and hospital purchasing firms like HealthTrust. Emphasizing the critical role of competition in the generic drug sector, it highlights regulatory obstacles and labor shortages impacting drug production, advocating for a harmonious balance between profit and healthcare quality.
Ask a question
How can regulatory bodies ensure a competitive environment in the generic drug market?
In what ways do price controls influence the balance between profit and quality in healthcare?
What strategies can healthcare institutions adopt to mitigate the impact of labor shortages on drug production?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Coverage